Total Payments
$444.81
2023 Payments
$15.59
Companies
8
Transactions
16
Medicare Patients
8,085
Medicare Billing
$662,898
Payment Breakdown by Category
Food & Beverage$392.06 (88.1%)
Education$52.75 (11.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $392.06 | 13 | 88.1% |
| Education | $52.75 | 3 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols USA, LLC | $139.60 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.32 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $72.10 | 1 | $0 (2017) |
| Mylan Specialty L.P. | $30.44 | 2 | $0 (2023) |
| Philips Electronics North America Corporation | $28.60 | 2 | $0 (2018) |
| CSL Behring | $27.30 | 1 | $0 (2020) |
| Paratek Pharmaceuticals, Inc. | $13.89 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $11.56 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.59 | 1 | Mylan Specialty L.P. ($15.59) |
| 2021 | $25.45 | 2 | Paratek Pharmaceuticals, Inc. ($13.89) |
| 2020 | $27.30 | 1 | CSL Behring ($27.30) |
| 2018 | $183.05 | 8 | Grifols USA, LLC ($139.60) |
| 2017 | $193.42 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($121.32) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/14/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: ANTIBIOTIC | ||||||
| 03/23/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 08/03/2020 | CSL Behring | Zemaira (Biological) | Education | In-kind items and services | $27.30 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/15/2018 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Pulmonology | ||||||
| 11/15/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Pulmonology | ||||||
| 10/24/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Pulmonology | ||||||
| 10/09/2018 | Philips Electronics North America Corporation | (8874) InCourage (Device) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Devices | ||||||
| 10/01/2018 | Philips Electronics North America Corporation | (8874) InCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Devices | ||||||
| 09/12/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Pulmonology | ||||||
| 08/23/2018 | Mylan Specialty L.P. | Dymista (Drug), Perforomist | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory and Allergy | ||||||
| 08/22/2018 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $101.15 | General |
| Category: Pulmonology | ||||||
| 04/03/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $60.04 | General |
| 03/22/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $72.10 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $47.39 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,009 | 2,613 | $445,228 | $148,854 |
| 2022 | 16 | 1,834 | 2,481 | $416,496 | $145,590 |
| 2021 | 17 | 1,973 | 2,800 | $464,244 | $175,115 |
| 2020 | 20 | 2,269 | 3,389 | $486,766 | $193,339 |
Total Patients
8,085
Total Services
11,283
Medicare Billing
$662,898
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 375 | 869 | $217,250 | $77,255 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 129 | 129 | $45,150 | $15,372 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 216 | $43,200 | $14,162 | 32.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 229 | 232 | $23,200 | $9,727 | 41.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 229 | 231 | $23,100 | $9,138 | 39.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 231 | 234 | $33,696 | $6,525 | 19.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 221 | 227 | $22,700 | $5,814 | 25.6% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 28 | 28 | $8,400 | $2,692 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $2,465 | $2,117 | 85.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 61 | 61 | $2,745 | $1,935 | 70.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 20 | 20 | $7,600 | $1,656 | 21.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 78 | 107 | $3,210 | $1,096 | 34.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 28 | 28 | $8,960 | $958.72 | 10.7% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 49 | 54 | $2,268 | $320.37 | 14.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 78 | 107 | $1,284 | $85.22 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 385 | 910 | $227,500 | $81,927 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 184 | $36,800 | $12,092 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $29,050 | $9,535 | 32.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 211 | 212 | $21,200 | $9,149 | 43.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 214 | 215 | $21,500 | $8,571 | 39.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 222 | 223 | $32,112 | $6,297 | 19.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 207 | 211 | $21,100 | $5,391 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 68 | $8,160 | $3,854 | 47.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 17 | 17 | $5,100 | $2,030 | 39.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 63 | $2,205 | $1,777 | 80.6% |
About Dr. Bipin Bhatt, MD
Dr. Bipin Bhatt, MD is a Pulmonary Disease healthcare provider based in Sebring, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396792263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bipin Bhatt, MD has received a total of $444.81 in payments from pharmaceutical and medical device companies, with $15.59 received in 2023. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($392.06).
As a Medicare-enrolled provider, Bhatt has provided services to 8,085 Medicare beneficiaries, totaling 11,283 services with total Medicare billing of $662,898. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Sebring, FL
- Active Since 05/27/2006
- Last Updated 01/19/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1396792263
Products in Payments
- Prolastin-C (Biological) $112.03
- BELSOMRA (Drug) $72.10
- (8874) InCourage (Device) $28.60
- Prolastin-C Liquid (Biological) $27.57
- Zemaira (Biological) $27.30
- YUPELRI (Drug) $15.59
- Dymista (Drug) $14.85
- NUZYRA (Drug) $13.89
- STIOLTO (Drug) $13.89
- BREZTRI (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Sebring
Deepak Patel, Md, MD
Pulmonary Disease — Payments: $12,880
Pulmonary Disease $12,880
Philip Wong, Md, MD
Pulmonary Disease — Payments: $6,078
Pulmonary Disease $6,078
Dennis Bassetti, Md, MD
Pulmonary Disease — Payments: $2,593
Pulmonary Disease $2,593
Dr. Guillermo Arias-Howard, M.d, M.D
Pulmonary Disease — Payments: $296.48
Pulmonary Disease $296.48
Padmaja Sajja, Md, MD
Pulmonary Disease
Pulmonary Disease